GENE ONLINE|News &
Opinion
Blog

2021-11-03| Licensing

Moderna Enters Gene Editing Market with Metagenomi Collaboration

by Daniel Ojeda
Share To
On Novermber 2nd, Cambridge, MA-based Moderna announced that it has entered into a strategic R&D collaboration with Metagenomi to advance new gene editing systems for in vivo human therapeutic applications.  The collaboration will bring together Metagenomi’s novel gene-editing tools with Moderna's mRNA platform and lipid nanoparticle (LNP) delivery technologies, to develop curative therapies for patients with serious genetic diseases.

Moderna jumped into the spotlight during the COVID-19 after it became one of the first companies to produce an effective vaccine using mRNA technology. This was Moderna’s first commercial product. Currently, most of their pipeline focuses on vaccine development, with their second most advanced product being a vaccine for Cytomegalovirus (CMV), currently in Phase 3 clinical trials. CMV is one of the leading causes of childhood hearing loss. Their pipeline also includes vaccines for Zika, influenza, and other viruses. 

However, their mRNA platform can be used to develop therapies beyond vaccines. For example, they are using their technology to develop instructions for cells to produce antibodies against the Chikungunya virus and autoimmune disorders. Due to the versatile nature of their mRNA platform, Moderna can expand to new markets. 

GO Prime with only $1.49 now

LATEST
Flagship-Backed ProFound Launches With $75 Million to Discover Human Proteins
2022-05-27
Janssen’s First Cell Therapy Gets Europe’s Approval for Multiple Myeloma
2022-05-27
Cell and Gene Therapy Landscape in Japan is Moving Beyond Oncology
2022-05-27
New Study Reveals Hope for Recovery of Patients with Spinal Cord Injury
2022-05-27
Laekna Therapeutics Announces Dosing of First Patients in the U.S. and China in Phase Ib/III Study of Afuresertib in Combination with Fulvestrant in HR+/HER2- Breast Cancer
2022-05-26
Stanford Touts Remote-Controllable CAR-T Cell Therapy
2022-05-26
Phenomix Launches The First Obesity Biobank Registry To Study Underling Phenotypes
2022-05-26
EVENT
2022-06-03
ASCO Annual Meeting
Online and on-side
2022-06-07
Digital RESI June
Online
2022-06-09
Medhospafrica
Africa
2022-06-13
BIO International Convention
San Diego, CA
2022-12-14
BIOHK2022
Hong Kong, China
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!